Ex parte MYERS et al. - Page 7


          Appeal No. 1999-1907                                                        
          Application No. 08/690,409                                                  


          Enzo Biochem Inc. v. Calgene, 188 F.3d 1362, 1371, 52 USPQ2d                
          1129, 1135 (Fed. Cir. 1999).  That is, even "a considerable                 
          amount of experimentation is permissible, if it is merely                   
          routine, or if the specification in question provides a                     
          reasonable amount of guidance with respect to the direction in              
          which the experimentation should proceed..."  Wands, 858 F.2d at            
          737, 8 USPQ2d at 1404.                                                      
               Here, the examiner's rejection does not even mention the               
          legal test of "undue experimentation," much less specifically               
          discuss any of the underlying factual inquiries adopted in                  
          Wands.  Again, that the "disclosure fails to teach one of                   
          ordinary skill in the art the composition of addition curable               
          silicone material" or that the complete chemical identity of                
          Castall S-1332 is not described in the specification is                     
          insufficient to satisfy the examiner's initial burden of proof              
          as to lack of enablement under 35 U.S.C. § 112, first paragraph.            
          Specifically, the appellants have argued that the examiner has              
          mischaracterized the invention as requiring "addition cured                 
          silicone."  (Appeal brief, pages 4-5.)  According to the                    
          appellants, any solvent-free polymer material other than the two            
          excluded polymers will work.  (Id. at pages 8-9.)  The examiner             




                                          7                                           



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007